Published in Br J Radiol on July 01, 1989
Isoeffective doses. Br J Radiol (1990) 0.75
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol (1997) 3.45
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! Int J Radiat Oncol Biol Phys (1995) 3.05
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet (1995) 3.03
National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol (R Coll Radiol) (2000) 2.95
Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions. Int J Radiat Oncol Biol Phys (1997) 2.48
Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol (1998) 2.30
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol (2000) 2.19
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA (1999) 2.16
Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol (1991) 2.11
Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys (1982) 2.05
How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat Res (1990) 1.83
Is the alpha/beta ratio for prostate cancer low? Int J Radiat Oncol Biol Phys (2001) 1.72
Volume effects in the irradiated canine spinal cord: do they exist when the probability of injury is low? Radiother Oncol (1998) 1.60
Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials. Radiother Oncol (1999) 1.58
Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys (1997) 1.58
Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume. Radiother Oncol (1994) 1.56
Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol (1989) 1.55
Radiation dose-fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model. Radiat Res (1993) 1.51
Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol (1990) 1.51
Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation. Eur J Cancer Clin Oncol (1988) 1.45
Long-term adverse effects of radiation inhibition of restenosis: radiation injury to the aorta and branch arteries in a canine model. Int J Radiat Oncol Biol Phys (1999) 1.44
Comparison of continuous and pulsed low dose rate brachytherapy: biological equivalence in vivo. Int J Radiat Oncol Biol Phys (1994) 1.42
The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys (1995) 1.40
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996. Int J Hyperthermia (2009) 1.39
Dose-response relationships for late radiation effects in the head and neck: regarding the analysis of the RTOG 8313 trial, Fu et al. IJROBP 32:577-588; 1995. Int J Radiat Oncol Biol Phys (1996) 1.39
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations. Int J Radiat Oncol Biol Phys (1995) 1.37
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) (1996) 1.31
An 'incomplete-repair' model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.27
Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol (1998) 1.27
The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol (1987) 1.26
Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys (1983) 1.25
A new isoeffect curve for change in dose per fraction. Radiother Oncol (1983) 1.23
Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol (1988) 1.23
Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat (2008) 1.21
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia (1996) 1.18
Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys (1994) 1.15
Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer (1992) 1.13
Variations in radiation sensitivity and repair among different hematopoietic stem cell subsets following fractionated irradiation. Blood (1995) 1.10
Repair in mouse lung between multiple small doses of X rays. Radiat Res (1983) 1.09
Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys (1996) 1.07
Clinical radiobiology of malignant melanoma. Radiother Oncol (1989) 1.07
Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol (1996) 1.07
Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol (1989) 1.06
Effect of dose-rate on total body irradiation: lethality and pathologic findings. Radiother Oncol (1985) 1.04
Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol (1994) 1.03
Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis. Acta Oncol (1998) 1.01
Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials. J Clin Oncol (2000) 1.01
Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys (2001) 1.01
Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. Br J Cancer (2002) 1.00
Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. Br J Cancer Suppl (1984) 1.00
The predictive value of quantitative computed tomography for vertebral body compressive strength and ash density. Bone (1989) 0.98
Prediction of radiotherapy response using SF2: why it may work after all. Radiother Oncol (1994) 0.97
Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients. J Clin Oncol (2001) 0.97
Impact of spinal cord repair kinetics on the practice of altered fractionation schedules. Radiother Oncol (1992) 0.96
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol (2007) 0.96
The relationship of acute to late skin injury in 2 and 5 fraction/week gamma-ray therapy. Int J Radiat Oncol Biol Phys (1979) 0.96
Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology. Eur J Cancer (2003) 0.96
Tumor radioresponsiveness versus fractionation sensitivity. Int J Radiat Oncol Biol Phys (1986) 0.95
Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer (1998) 0.94
An evolutionary-game model of tumour-cell interactions: possible relevance to gene therapy. Eur J Cancer (2001) 0.94
Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys (1991) 0.93
Use of tumour markers in monitoring the course of ovarian cancer. Ann Oncol (1999) 0.92
Tumor radioresistance in clinical radiotherapy. Int J Radiat Oncol Biol Phys (1982) 0.92
Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma. Strahlenther Onkol (2012) 0.91
Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients. Int J Radiat Oncol Biol Phys (2000) 0.91
The prognostic effect of tobacco and alcohol consumption in intra-oral squamous cell carcinoma. Eur J Cancer B Oral Oncol (1994) 0.91
Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood (1991) 0.91
The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation. Int J Radiat Oncol Biol Phys (1989) 0.91
Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys (1989) 0.91
Evaluation of the spatial resolution of a CT scanner by direct analysis of the edge response function. Med Phys (1984) 0.90
Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys (1989) 0.90
Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol (R Coll Radiol) (2012) 0.90
Delay in the diagnosis of oral squamous cell carcinoma. Clin Otolaryngol Allied Sci (1995) 0.90
Tumor cell proliferation and survival in patients with prostate cancer followed expectantly. J Urol (1998) 0.90
The results of colorectal cancer treatment by p53 status: treatment-specific overview. Dis Colon Rectum (2001) 0.90
The translational research chain: is it delivering the goods? Int J Radiat Oncol Biol Phys (2001) 0.90
Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res (1982) 0.90
Time factors in breast carcinoma: influence of delay between external irradiation and brachytherapy. Radiother Oncol (1992) 0.89
Histological differentiation of oral squamous cell cancer in relation to tobacco smoking. Eur J Cancer B Oral Oncol (1995) 0.89
Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol (1994) 0.89
On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy. Med Dosim (2009) 0.89
Clinical radiation doses for spinal cord: the 1998 international questionnaire. Radiother Oncol (2000) 0.89
Test of equal effect per fraction and estimation of initial clonogen number in microcolony assays of survival after fractionated irradiation. Br J Radiol (1980) 0.88
Fractionation response and repair kinetics of radiation-induced heart failure in the rat. Radiother Oncol (1992) 0.88
Recovery from radiation damage in mouse lung: interpretation in terms of two rates of repair. Radiat Res (1993) 0.88
Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation. Radiother Oncol (1993) 0.88
Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother Oncol (1996) 0.87
A dose-surviving fraction curve for mouse colonic mucosa. Eur J Cancer Clin Oncol (1983) 0.87
Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial. Radiother Oncol (1999) 0.87
bcl-2 expression in head and neck cancer: an enigmatic prognostic marker. Int J Radiat Oncol Biol Phys (2001) 0.86
Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy. Radiother Oncol (1998) 0.86
Density changes at the proximal tibia after medial meniscectomy. J Orthop Res (1989) 0.85
Risk factors for central nervous system involvement in non-Hodgkins-lymphoma--a multivariate analysis. Acta Oncol (1996) 0.85